
Voglibrex 0.2 Tablet
Marketer
Mcbrex Lifesciences
Salt Composition
Voglibose (0.2mg)
Overview Voglibrex 0.2 Tablet
GlycemaControl 0.2mg tablets are prescribed for managing type 2 diabetes. This medication helps regulate postprandial hyperglycemia (high blood sugar after meals). It's indicated when dietary modifications and other similar treatments prove insufficient in controlling elevated blood glucose levels. GlycemaControl 0.2mg tablets should be administered immediately before meals. Your physician will determine the appropriate dosage and frequency to effectively manage your blood sugar. Abrupt cessation without medical consultation is strongly discouraged; it can lead to dangerously high blood sugar and potentially severe complications, including renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Common side effects include gastrointestinal discomfort (flatulence, abdominal pain, decreased appetite, constipation, diarrhea). Report persistent or troublesome side effects to your doctor. GlycemaControl 0.2mg tablets do not independently cause hypoglycemia. However, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) increases the risk of hypoglycemic episodes, requiring treatment with simple glucose (not sucrose or other sugars). Inform your doctor of any pre-existing liver or kidney conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Always disclose all other medications to ensure safe and effective treatment. Excessive alcohol consumption should be avoided, as it may heighten the risk of hypoglycemia.
Primary Ingredients of Voglibrex 0.2 Tablet
No text provided to rephrase.
Uses of Voglibrex 0.2 Tablet
Managing Type 2 Diabetes
Major Benefits of Voglibrex 0.2 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglibrex 0.2 Tablet should be administered on an empty stomach.
Common Side effects of Voglibrex 0.2 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglibrex 0.2 Tablet:
Administer Voglibrex 0.2 Tablet precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication on an empty stomach.
How Voglibrex 0.2 Tablet works:
Voglibrex 0.2mg tablets are used to manage diabetes. Their mechanism involves blocking intestinal enzymes that digest complex carbohydrates, thus moderating postprandial glucose spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglibrex 0.2 Tablet with alcohol is contraindicated.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Voglibrex 0.2 Tablet is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; however, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on current evidence, it's likely safe to take Voglibrex 0.2 Tablet while breastfeeding. Available data from human studies indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Voglibrex 0.2 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Voglibrex 0.2 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglibrex 0.2 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglibrex 0.2 Tablet :
Omit any missed dose of Voglibrex 0.2 Tablet and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Voglibrex 0.2 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |
